Her main research concerns Closed head injury, Traumatic brain injury, Pharmacology, Endocrinology and Internal medicine. Her Closed head injury research is multidisciplinary, relying on both Anesthesia, Central nervous system disease, Cytokine, Edema and Pathology. Her study in Traumatic brain injury is interdisciplinary in nature, drawing from both Reactive oxygen species, Pharmacological therapy, Physical therapy and Ischemia.
Her research on Pharmacology focuses in particular on Neuroprotection. Her studies deal with areas such as Lesion and Osteoblast as well as Endocrinology. In her research on the topic of Internal medicine, In vivo, Toxicity, Nap, Apolipoprotein B and Apolipoprotein E is strongly related with Head trauma.
Esther Shohami focuses on Internal medicine, Endocrinology, Traumatic brain injury, Closed head injury and Neuroprotection. Her Ischemia, Dexamethasone and Uric acid study in the realm of Internal medicine connects with subjects such as Ascorbic acid. In the field of Endocrinology, her study on Oxidative stress, Prostaglandin E2 and Prostaglandin overlaps with subjects such as Eicosanoid.
Her research in Traumatic brain injury intersects with topics in Brain damage, Neuroscience, Inflammation, Neuroinflammation and Glutamate receptor. Her work is dedicated to discovering how Closed head injury, Anesthesia are connected with NMDA receptor and Antagonist and other disciplines. Her study with Neuroprotection involves better knowledge in Pharmacology.
Her primary areas of study are Traumatic brain injury, Neuroprotection, Neuroscience, Pharmacology and Anesthesia. Her Traumatic brain injury research is multidisciplinary, incorporating elements of Stroke, Internal medicine, Lesion and Endocrinology. Her Neuroprotection research is multidisciplinary, relying on both Neurogenesis, Biochemistry, Endocannabinoid system and Nerve growth factor.
Her Neuroscience study combines topics from a wide range of disciplines, such as Glutamate receptor, Long-term potentiation, Neuroinflammation and NMDA receptor. Esther Shohami combines subjects such as Edema, Cord blood, Receptor, Neurotrophin and Ischemia with her study of Pharmacology. Her Anesthesia research integrates issues from Inflammation, Brain lesions and Surgery.
Her primary scientific interests are in Traumatic brain injury, Neuroprotection, Anesthesia, Neuroscience and Stroke. Her Traumatic brain injury research includes elements of Cancer research, Cortex, Ischemia, Proinflammatory cytokine and Neural stem cell. The subject of her Neuroprotection research is within the realm of Pharmacology.
Her study in Pharmacology is interdisciplinary in nature, drawing from both Protein Kinase M and Edema. The study incorporates disciplines such as Gliogenesis, Lesion, Endocrinology and Internal medicine in addition to Anesthesia. Her Stroke study integrates concerns from other disciplines, such as Closed head injury, Histone, Clinical trial and Central nervous system.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
An endogenous cannabinoid (2-AG) is neuroprotective after brain injury
David Panikashvili;Constantina Simeonidou;Shimon Ben-Shabat;Lumír Hanuš.
Cerebral ischemia and trauma-different etiologies yet similar mechanisms: neuroprotective opportunities.
Ronen R Leker;Esther Shohami.
Brain Research Reviews (2002)
Dual role of tumor necrosis factor alpha in brain injury
Esther Shohami;Irene Ginis;John M Hallenbeck.
Cytokine & Growth Factor Reviews (1999)
Peripheral cannabinoid receptor, CB2, regulates bone mass
Orr Ofek;Meliha Karsak;Nathalie Leclerc;Meirav Fogel.
Proceedings of the National Academy of Sciences of the United States of America (2006)
An experimental model of closed head injury in mice: pathophysiology, histopathology, and cognitive deficits.
Yun Chen;Shlomo Constantini;Victoria Trembovler;Marta Weinstock.
Journal of Neurotrauma (1996)
Closed Head Injury Triggers Early Production of TNFα and IL-6 by Brain Tissue:
E. Shohami;M. Novikov;R. Bass;A. Yamin.
Journal of Cerebral Blood Flow and Metabolism (1994)
Mouse closed head injury model induced by a weight-drop device
Michael A Flierl;Philip F Stahel;Kathryn M Beauchamp;Steven J Morgan.
Nature Protocols (2009)
Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-α inhibitor and an effective neuroprotectant
E Shohami;R Gallily;R Mechoulam;R Bass.
Journal of Neuroimmunology (1997)
Inhibition of Tumor Necrosis Factor Alpha (TNFα) Activity in Rat Brain is Associated with Cerebroprotection after Closed Head Injury
E Shohami;R Bass;D Wallach;A Yamin.
Journal of Cerebral Blood Flow and Metabolism (1996)
Rapamycin is a neuroprotective treatment for traumatic brain injury.
S. Erlich;A. Alexandrovich;E. Shohami;R. Pinkas-Kramarski.
Neurobiology of Disease (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: